re: Ann: MVP Announcement - Successful Clini... The company said, in their recent address to shareholders:
"We expect to hear back from the Regulatory Authorities in
February 2014 as to the status of our application."
____
Not sure if "status" means yes or no. I presume it does. If Penthrox can go all over the world- and it really is a one of a kind product- MVP's share price will well and truly earn its PE/r.
Ann: MVP Announcement - Successful Clinical Stud, page-12
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.015(3.85%) |
Mkt cap ! $34.95M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 42.0¢ | 39.0¢ | $77.77K | 194.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 163 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
41.5¢ |
Change
0.015 ( 3.18 %) |
||||
| Open | High | Low | Volume | ||
| 39.0¢ | 42.0¢ | 39.0¢ | 54624 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| MVP (ASX) Chart |